Mukthinuthalapati Mathrusri Annapurna* and Sneha Das

GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India

*Corresponding Author: Mukthinuthalapati Mathrusri Annapurna, GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.

Received: November 28, 2025; Published: December 31, 2025

Abstract

Risperidone is an anti-psychotic drug to reduce this overactivity through inhibition of dopaminergic D2 receptors and serotonergic 5-HT2A receptors in the brain. In the present study the authors have summarised the analytical methods so far published for the estimation of Resperidone in the literature.

Keywords: Risperidone; Liquid Chromatographic Method

References

1. Fenton C and Scott LJ. “Risperidone: A review of its use in the treatment of bipolar mania”. CNS Drugs5 (2005): 429-444.
2. Kemp DE., et al. “Long-acting Risperidone: A review of its role in the treatment of bipolar disorder”. Advances in Therapy6 (2009): 588-599.
3. Jayanna BK., et al. “Spectrophotometric estimation of Risperidone in tablets”. Indian Journal of Pharmaceutical Sciences 5 (2014): 452-455.
4. Sravan Kumar M., et al. “Development of analytical method for Risperidone by UV spectrophotometry”. International Journal of Pharma Sciences and Research2 (2010): 122-126.
5. Lakshmi Prasanna I., et al. “Spectrophotometric method for the determination of Risperidone in the presence of Trihexyphenidyl HCl by ion-pair complex method using bromo cresol green”. Human Journals 2 (2018): 148-159.
6. Sheeja Velayudhan Kutty., et al. “Development and validation of spectrophotometric method for the determination of Risperidone in pure and pharmaceutical formulation using MBTH reagent”. Research Journal of Pharmacy and Technology 4 (2013): 388-391.
7. Moynul Hasan., et al. “Development and validation of spectrophotometric method for the determination of Risperidone in bulk drug and pharmaceutical formulation”. International Journal of Pharmaceutical Sciences and Research2 (2011): 378-382.
8. Krishna Prasad D., et al. “UV spectrophotometric method for Risperidone tablet estimation”. World Journal of Pharmaceutical Research9 (2023): 2219-2225.
9. Ashok PS., et al. “New simple, sensitive and economical UV spectrophotometric method for estimation of Risperidone in tablet dosage form and its peroxide degradation kinetic”. Research Journal of Pharmaceutical Dosage Forms and Technology 2 (2009): 126-129.
10. Puja RP., et al. “Spectrophotometric estimation of Risperidone in pure and tablet dosage forms”. International Journal of Novel Research and Development4 (2023) b716-b727.
11. Khalid AM., et al. International Journal of Pharmacy and Pharmaceutical Research 4 (2015) 124-138.
12. Orhan Cakirer and Ibrahim Hudai Tasdemir. “Electrochemical and spectrophotometric methods to assay of Risperidone an antipsychotic drug in pharmaceutical and biological samples”. Asian Journal of Chemistry8 (2010) 6353-6365.
13. Hemavathi N Deepakumari and Hosakere DR. “Development and validation of a highly sensitive spectrophotometric method for the estimation of Risperidone in pure and in dosage forms”. Analytical Chemistry an Indian Journal4 (2014) 121-126.
14. Khan K., et al. “Determination of Risperidone in pharmaceutical products by UV-spectrophotometry and RP-HPLC: Method development and validation”. International Journal of Biology, Pharmacy and Allied Sciences 3 (2018): 289-301.
15. Sheeja Velayudhan Kutty., et al. “Difference spectrophotometric method for the determination of Risperidone in bulk and tablet dosage form”. The Pharma Innovation Journal2 (2013) 44-49.
16. Kathirvel S., et al. “UV spectrophotometric determination of Risperidone in bulk and its formulation”. Asian Journal of Research in Chemistry1 (2010) 151-153.
17. Narayana B and Divya NS. “Development and validation of spectrophotometric method for the determination of Risperidone”. Der Pharmacia Lettre 5 (2011) 104-109.
18. Hassouna MEM and Zaki GA. “Spectrophotometric determination of Risperidone in pharmaceutical preparations by Charge-Transfer Reactions”. International Journal of Advanced Research4 (2014) 453-461.
19. Anil Kumar G and Rajveer Chiliveri. “Development and validation of UV-Visible spectrophotometric methods for the assay of Risperidone in tablets”. Res Militaris4 (2023) 6716-6722.
20. Amod Shivaji Patil., et al. “Quantitative UV-spectrophotometry estimation of Risperidone using hydrotropic solubilization phenomenon”. International Journal of Advances in Pharmaceutical Analysis 3 (2015): 58-60.
21. Vejandla Swathi Lakshmi., et al. “Development and validation of new spectrophotometric methods for the estimation of Risperidone”. Research Journal of Pharmacy and Technology7 (2025): 3336-3339.
22. Ashour S and Kattan N. “Sensitive method for the quantitative determination of Risperidone in tablet dosage form by high-performance liquid chromatography using chlordiazepoxide as internal standard”. International Journal of Biomed Sciences2 (2013): 91-97.
23. Zarna R Dedania., et al. “Stability indicating HPLC determination of Risperidone in bulk drug and pharmaceutical formulations”. International Journal of Analytical Chemistry (2011): 6.
24. Alivelu Samala., et al. “Development and validation of RP-HPLC method for estimation of Risperidone in tablet dosage form”. Research Journal of Pharmacy and Technology6 (2013): 659-661.
25. Kathirvel S and Suneetha A. “A validated RP- HPLC method for estimation of risperidone in oral solution”. Research Journal of Pharma Dosage Forms and Tech4 (2011): 139-141.
26. Krishna Sankaa., et al. “Method development and validation for estimation of Risperidone in novel liquisolid formulation by RP-HPLC”. Der Pharmacia Lettre1 (2014): 166-174.
27. Mennickent S., et al. “Stability indicating HPLC method for quantification of Risperidone in tablets”. Journal of the Chilean Chemical Society3 (2018): 4150-4154.
28. Darren Svirskis., et al. “A Stability indicating HPLC Method for the determination of electrochemically controlled release of Risperidone”. Journal of Chromatographic Science10 (2011): 780-785.
29. , et al. “In vitro examine of Risperidone in drug tablet dose structure using reverse phase fluid chromatographic (RP-HPLC) strategy”. International Journal of Biology, Pharmacy and Allied Sciences 10.12 (2021): 74-80.
30. , et al. “Analytical method development and validation for quantitative estimation of antipsychotic drug in pharmaceutical dosage form by RP-HPLC method”. Indo American Journal of Pharmaceutical Sciences 10.5 (2023): 241-247.
31. Syed Sarim Imam., et al. “Optimization of mobile phase by 32-mixture design for the validation and quantification of Risperidone in bulk and pharmaceutical formulations using RP-HPLC”. Analytical Methods 6 (2014): 282-288.
32. Silva AC., et al. “Risperidone release from solid lipid nanoparticles (SLN): Validated HPLC method and modelling kinetic profile”. Current Pharmaceutical Analysis4 (2012): 307-316.
33. Baldania SL., et al. “RP-HPLC Estimation of Risperidone in tablet dosage forms”. Indian Journal of Pharmaceutical Sciences 4 (2008): 494-497.
34. Gayatri Patra. “Method development and validation of Risperidone by using RP - HPLC and its stress studies”. International Journal of Enhanced Research in Science, Technology & Engineering7(2023): 122-131.
35. Suthar AP., et al. “Determination of Risperidone and forced degradation behavior by HPLC in tablet dosage form”. International Journal of Pharm Tech Research3 (2009): 568-574.
36. Manikandan K and Lakshmi KS. “Method development and validation of Risperidone by RP-HPLC”. International Journal of Research in Pharmaceutical and Nano Sciences1 (2012): 87-95.
37. Bhavana AK., et al. “RP-HPLC method development and validation for estimation of Risperidone in bulk & dosage forms”. International Journal of Pharmaceutical Sciences Review and Research1 (2019): 29-32.
38. Yunoos Mohammad., et al. “Development and validated new reverse phase high performance liquid chromatographic method for the determination of Risperidone in bulk and tablet dosage forms”. Research Journal of Pharmaceutical Biological and Chemical Sciences2 (2010): 165-171.
39. Nejedly T., et al. “Development and validation of rapid UHPLC method for determination of Risperidone and its impurities in bulk powder and tablets”. International Journal of Research in Pharmacy and Chemistry2 (2014): 261-266.
40. Lakshmi B., et al. “Development and validation of RP-HPLC method for the estimation of Risperidone in bulk and pharmaceutical dosage form”. Der Pharmacia Lettre3 (2015): 221-227.
41. Naveen Kumar K and Venugopal Reddy P. “Risperidone was developed and validated by reverse phase method”. Anveshana’s International Journal of Research in Pharmacy and Life Sciences4 (2023): 48-56.

Citation

Citation: Mukthinuthalapati Mathrusri Annapurna and Sneha Das. “Analytical Techniques for the Assay of Risperidone: A Review". Acta Scientific Pharmaceutical Sciences 10.1 (2026): 50-55.

Copyright

Copyright: © 2026 Mukthinuthalapati Mathrusri Annapurna and Sneha Das. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.